Zhejiang Cancer Hospital

This study tests a new drug combination (Sac-TMT plus a targeted therapy, with or without radiation) in 45 adults with a specific type of lung cancer that has spread to the brain and stopped responding to previous treatment. The goal is to see if the combination can control the c…

This early-stage study tests whether cells from umbilical cord blood can safely help people with long-term gut damage from radiation therapy. Ten adults who have had pelvic or belly radiation will receive the treatment. The main goal is to check for side effects and see if bowel …

This study tests a powerful two-step treatment for people with relapsed or treatment-resistant large B-cell lymphoma that has high-risk features. First, patients receive CAR-T cells (engineered immune cells) followed by a stem cell transplant. The goal is to see if this combinati…